Inventor

ZHU ZHONGYU

US52 patents

⚠️ This page may combine multiple inventors who share the name “ZHU ZHONGYU”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

ZHU ZHONGYU

LENTIGEN TECH INC

Compositions and methods for treating cancer with anti-CD123 immunotherapy

Compositions and methods for treating cancer with anti-CD33 immunotherapy

Compositions and methods for treating cancer with anti-ROR1 immunotherapy

Compositions and methods for treating cancer with anti-CD38 immunotherapy

Compositions and methods for treating cancer with anti-mesothelin immunotherapy

Compositions and methods for treating cancer with anti-CD19 immunotherapy

Compositions and methods for treating cancer with anti-mesothelin immunotherapy

Compositions and methods for treating cancer with anti-BCMA immunotherapy

Compositions and methods for treating cancer with anti-ROR1 immunotherapy

Compositions and methods for treating cancer with anti-CD123 immunotherapy

Compositions and methods for treating cancer with anti-ROR1 immunotherapy

Compositions and methods for treating cancer with anti-CD38 immunotherapy

Compositions and methods for treating cancer with anti-CD123 immunotherapy

Compositions and methods for treating cancer with anti-mesothelin immunotherapy

Compositions and methods for treating cancer with anti-CD19 immunotherapy

Compositions and methods for treating cancer with anti-CD33 immunotherapy

Compositions and methods for treating cancer with anti-BCMA immunotherapy

US HEALTH

Anti-CD276 polypeptides, proteins, and chimeric antigen receptors

TEM8 antibodies and their use in treatment and detection of tumors

Human monoclonal antibodies against Hendra and Nipah viruses

HER2-specific monoclonal antibodies and conjugates thereof

Antibody-drug conjugates for targeting CD56-positive tumors

Monoclonal antibodies specific for fibroblast growth factor receptor 4 (FGFR4) and methods of their use

Human monoclonal antibody targeting TNFR2 for cancer immunotherapy

Monoclonal antibodies specific for fibroblast growth factor receptor 4 (FGFR4) and methods of their use

Affinity matured CD22-specific monoclonal antibody and uses thereof

Monoclonal antibodies that specifically bind to matrilin 3 and their use

Human monoclonal antibodies that bind insulin-like growth factor (IGF) I and II

TEM8 antibodies and their use in treatment and detection of tumors

Agents that specifically bind matrilin-3 and their use

BIOMED VALLEY DISCOVERIES INC

Combination therapies targeting tumor-associated stroma or tumor cells and topoisomerase

Combination therapies targeting tumor-associated stroma or tumor cells and microtubules

Combination therapies targeting tumor-associated stroma or tumor cells

Combination therapies using agents that target tumor-associated stroma or tumor cells and tumor vasculature

Combination therapies using agents that target tumor-associated stroma or tumor cells and alkylating agents

Combination therapies using anti-metabolites and agents that target tumor-associated stroma or tumor cells

DIMITROV DIMITER S

Human monoclonal antibodies that bind human insulin like growth factors and their use

Human monoclonal antibodies against hendra and nipah viruses

Human monoclonal antibodies that bind insulin-like growth factor (IGF) I and II

LENTIGENTECHNOLOGY INC

Compositions and methods for treating cancer with anti-CD22 immunotherapy

Compositions and methods for treating cancer with anti-CD22 immunotherapy

THE US SECRETARY DEPARTMENT OF HEALTH

Anti-CD276 antibodies (B7H3)

Anti-CD276 antibodies (B7H3)

THE UNITED STATES OF AMERICA AS PRESENTED BY THE SEC DEP OF HEALTH AND HUMAN SERVICES

Anti-CD276 polypeptides, proteins, and chimeric antigen receptors

Anti-CD276 polypeptides, proteins, and chimeric antigen receptors

JACKSON H M FOUND MILITARY MED

Human monoclonal antibodies against Hendra and Nipah viruses

CHILDRENS HOSPITAL PHILADELPHIA

Glypican 2 as a cancer marker and therapeutic target

THE US SECRETARY DEPARTMENT OF HEALTH AND HUMAN SERVICES THE GOVERNMENT

Monoclonal antibodies that specifically bind to matrilin-3 and their use

THE USA AS REPRESENTED BY THE SECRETARY DEPT OF HEALTH AND HUMAN SERVICES

Cross-reactive antibodies against dengue virus and uses thereof

MEMORIAL SLOAN KETTERING CANCER CENTER

ADAM17 binding molecules and uses thereof